|
AKAP13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.177600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.272800E-01 |
| Normal-vs-Stage2 |
6.837600E-02 |
| Normal-vs-Stage3 |
2.331000E-01 |
| Normal-vs-Stage4 |
8.909200E-01 |
| Stage1-vs-Stage2 |
1.090820E-01 |
| Stage1-vs-Stage3 |
3.922200E-01 |
| Stage1-vs-Stage4 |
7.271800E-01 |
| Stage2-vs-Stage3 |
3.482600E-01 |
| Stage2-vs-Stage4 |
1.435370E-01 |
| Stage3-vs-Stage4 |
3.595200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.834000E-01 |
| Normal-vs-AfricanAmerican |
3.663400E-01 |
| Normal-vs-Asian |
5.549400E-01 |
| Caucasian-vs-AfricanAmerican |
2.047800E-01 |
| Caucasian-vs-Asian |
9.902400E-01 |
| AfricanAmerican-vs-Asian |
2.323800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.001900E-02 |
| Normal-vs-Female |
6.429600E-01 |
| Male-vs-Female |
1.300390E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.104800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.764800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.795600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.254190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.361600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.183500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.366200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.353800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.709800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.141000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.778200E-02 |
| Classical-VS-Follicular |
3.30410000004555E-06 |
| Classical-VS-Other |
2.804000E-01 |
| Classical-VS-Normal |
7.605600E-01 |
| Tall-VS-Follicular |
4.640100E-02 |
| Tall-VS-Other |
5.594400E-01 |
| Tall-VS-Normal |
2.676400E-01 |
| Follicular-VS-Other |
6.608200E-01 |
| Follicular-VS-Normal |
1.518030E-03 |
| Other-VS-Normal |
2.554000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.776300E-02 |
| Normal-vs-N1 |
7.068800E-01 |
| N0-vs-N1 |
1.798360E-01 |
|
|
